WuXi Biologics (Cayman) Inc. (HKG:2269)
32.54
+1.10 (3.50%)
At close: Jan 2, 2026
Revenue by Product
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.